Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
Juan Gómez, Guillermo M. Albaiceta, Marta García‐Clemente, Carlos López‐Larrea, Laura Amado‐Rodríguez, Inés López-Alonso, Tamara Hermida, Ana I. Enríquez, Pablo Herrero, Santiago Melón, Marta Elena Álvarez‐Argüelles, José Antonio Boga, Susana Rojo‐Alba, Elías Cuesta‐Llavona, Victoria Álvarez, Rebeca Lorca, Eliécer Coto
Topics & Concepts
BiologyAngiotensin-converting enzyme 2PathogenesisLogistic regressionGenotypeInternal medicineSingle-nucleotide polymorphismPolymorphism (computer science)Coronavirus disease 2019 (COVID-19)Angiotensin-converting enzymeGeneEndocrinologyImmunologyBioinformaticsDiseaseGeneticsMedicineBlood pressureInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Impact on Reproduction